Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Shulgin Farm Announces Seed Crystal Campaign to Preserve Psychedelic History and Build Community Hub


News provided by

Shulgin Farm

Apr 18, 2024, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Alexander "Sasha" Shulgin in his laboratory - Photo by Dennis Galloway
Alexander "Sasha" Shulgin in his laboratory - Photo by Dennis Galloway

Sasha and Ann Shulgin were pioneers of modern psychedelic research

LAFAYETTE, Calif., April 18, 2024 /PRNewswire-PRWeb/ -- The Shulgin Farm, the legendary site where Alexander "Sasha" Shulgin synthesized and, together with his wife Ann Shulgin, studied over 200 psychedelic compounds, is embarking on a new chapter. The nonprofit organization has announced the Seed Crystal Campaign to transform the Farm into a center for educational and community-focused events, formal and informal gatherings, and historic preservation.

The Shulgins were pioneers in psychedelic science whose impact reverberates to this day. In 1976, Sasha resynthesized MDMA and discovered its profound psychological effects. He and Ann, a lay therapist, saw the compound's potential to foster empathy and catalyze emotional healing. Their advocacy and insight into MDMA's potential as a therapeutic tool laid the groundwork for today's cutting-edge research into psychedelic-assisted therapy.

With the psychedelic movement blossoming, it's the perfect time to open the Farm's doors to everyone who dreams of a wiser, kinder, and more connected world.

Post this

"Sasha and Ann devoted their lives to understanding psychedelics as tools for growth and healing," said Wendy Tucker, Ann's daughter and Chair of the Shulgin Farm Board of Directors. "Sasha used to say that taking a psychedelic was like opening a door to a rich and fascinating room. The Farm was the safe space where they mapped those inner worlds."

Over more than four decades, with the knowledge and permission of authorities, the Shulgins meticulously documented the subjective effects of hundreds of novel psychoactive compounds. Their influential books PiHKAL and TiHKAL, based on their groundbreaking research, have inspired countless scientists, therapists, and explorers of consciousness.

Now, the psychedelic community has the chance to continue the Shulgins' journey of discovery by supporting Shulgin Farm's preservation and evolution. The Seed Crystal Campaign, named after the catalytic role of seed crystals in sparking growth, aims to raise $3 million to establish the Farm as a psychedelic cultural center. Donors who contribute $10,000 or more will be honored as Seed Crystal Stewards.

Funds from the campaign will be used to acquire the property, house the Shulgin archive, improve facilities, and create an inviting space for seminars, weddings, and events at the intersection of psychedelic science, therapy, art, and spirituality. By protecting this historic site, Shulgin Farm will educate and inspire future generations.

The Shulgins' legacy has never been more relevant. Clinical trials are demonstrating the efficacy of psychedelics like MDMA and psilocybin for treating PTSD, depression, addiction, and end-of-life anxiety. Prestigious institutions including Johns Hopkins and NYU have opened psychedelic research centers. Governments are reevaluating prohibitionist drug policies. Amid this "psychedelic renaissance," Shulgin Farm will be a vital hub.

"Ann and Sasha showed us how to work responsibly with psychedelics to explore the mind, nurture well-being, and build community," noted Tucker. "They grew a worldwide family from their home. With the psychedelic movement blossoming, it's the perfect time to open the Farm's doors to everyone who dreams of a wiser, kinder, and more connected world."

To learn more about the Seed Crystal Campaign or make a donation, visit shulginfarm.org or contact [email protected].

For more background on the Shulgins' contributions to the psychedelic renaissance, see:

  • The New York Times: Alexander Shulgin, Psychedelia Researcher, Dies at 88
  • The New York Times: Ann Shulgin, 91, Who Explored Psychedelics With Her Husband, Dies
  • Interview Magazine: Love and Other Drugs
  • Film: Better Living Through Chemistry (2021)
  • Film: Dirty Pictures (2010)

Media Contact
Brad Burge, Shulgin Farm, 1 6508636887, [email protected], https://shulginfarm.org

SOURCE Shulgin Farm

Modal title

Ann and Sasha Shulgin, beloved pioneers of the psychedelic renaissance
Ann and Sasha Shulgin, beloved pioneers of the psychedelic renaissance
The Shulgin Farm logo.
The Shulgin Farm logo.
Ann and Sasha Shulgin, beloved pioneers of the psychedelic renaissance The Shulgin Farm logo.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.